See what you missed at ASRM 2024 with the ASRM 2024 Recorded Bundle
Intracytoplasmic sperm injection, while typically effective for overcoming low or absent fertilization in couples with a clear abnormality of semen parameters, is frequently used in combination
The summary presented herein represents Part II of the two-part series dedicated to the Diagnosis and Treatment of Infertility in Men: AUA/ASRM Guideline.
I came across your site as I was trying to do some research on what diagnosis codes providers should submit to insurance carriers while trying to evaluate fertility issues. If the prescriber is
Clinical trials testing infertility treatments often do not report on the major outcomes of interest to patients and clinicians and the public (such as live birth) nor on the harms, including
The most common test of a man’s fertility is a semen analysis.
About 20% of infertility cases are due to a male factor alone. Another 30% involves both male and female factors.
While intracytoplasmic sperm injection (ICSI) has revolutionized the treatment of male factor infertility, a significant controversy still remains regarding its ubiquitous use in all IVF cycles.
My group was wondering if and how to code for a male partner consultation. We and others we know code only for a new female patient visit but we do see both the male and female, take two
The American Urological Association (AUA), in collaboration with the American Society for Reproductive Medicine (ASRM), has released the 2024 amendment to the Male Infertility Guideline.
We perform test thaws to determine if frozen TESE specimens from other clinics are suitable for our procedures.
Displaying 41 to 50 of 56 records
